List of the Drugs Going Off Patent in Near Future

2
List of the drugs going off patent in near future Sr. No. Name of the drug Category Patent Holder Expiry Year 1. Zafirlukast Respirato ry Glaxo Sept. 2010 2. Zelienton Respirato ry Abbott Dec., 2010 3. Atrovastatin Cal. C.V. Wartner Dec., 2010 4. Irbesartan C.V. Sanofi March, 2011 5. Olanzapine C.N.C. Eli Lilly April, 2011 6. Tirofiban C.V. Merck March, 2011 7. Rosuvastatin C.V. A.Z. June, 2012 8. Zolmitriptan Migraine A.Z. Nov., 2012 9. Frovatriptan C.N.C. GSK Nov., 2012 10. Valsortan C.V. Novartis March, 2012 11. Ertapenem Antibioti c Merck Feb, 2013 12. Caspofungi Antibioti c Merck March, 2013 13. Voriconazole Antibioti c Pfizer Oct, 2013 14. Rizatriptan Migraine Merck Jan., 2013 15. Eletriptan Migraine Merck Aug. 2013 16. Almotriptan Migraine Pharmacia Oct, 2013 17. Teriparatide Hormone Eli Lilly July, 2013 18. Risedronate Sodium Hormone P & G Dec, 2013 19. Imatinib Mesylate Oncology Novartis May, 2013 20. Insulin Lispro Diabetes Eli Lilly May, 2013 21. Insulin Aspart Diabetes Novo Sept, 1013 22. Rituximab Biopharm Gentech March, 2013 23. Decliximab Biopharm Protein Design June, 2013 24. Erytropoietin Biopharm Amgen Aug, 2013 25. Palvizumab Biopharm Medi Immune Dec., 2013 26. Tegaserod Gastro Novartis April, 2013

Transcript of List of the Drugs Going Off Patent in Near Future

Page 1: List of the Drugs Going Off Patent in Near Future

List of the drugs going off patent in near future

Sr. No.

Name of the drug Category Patent Holder Expiry Year

1. Zafirlukast Respiratory Glaxo Sept. 20102. Zelienton Respiratory Abbott Dec., 20103. Atrovastatin Cal. C.V. Wartner Dec., 20104. Irbesartan C.V. Sanofi March, 20115. Olanzapine C.N.C. Eli Lilly April, 20116. Tirofiban C.V. Merck March, 20117. Rosuvastatin C.V. A.Z. June, 20128. Zolmitriptan Migraine A.Z. Nov., 20129. Frovatriptan C.N.C. GSK Nov., 201210. Valsortan C.V. Novartis March, 201211. Ertapenem Antibiotic Merck Feb, 201312. Caspofungi Antibiotic Merck March, 201313. Voriconazole Antibiotic Pfizer Oct, 201314. Rizatriptan Migraine Merck Jan., 201315. Eletriptan Migraine Merck Aug. 201316. Almotriptan Migraine Pharmacia Oct, 201317. Teriparatide Hormone Eli Lilly July, 201318. Risedronate

SodiumHormone P & G Dec, 2013

19. Imatinib Mesylate Oncology Novartis May, 201320. Insulin Lispro Diabetes Eli Lilly May, 201321. Insulin Aspart Diabetes   Novo Sept, 101322. Rituximab Biopharm Gentech March, 201323. Decliximab Biopharm Protein Design June, 201324. Erytropoietin Biopharm Amgen Aug, 201325. Palvizumab Biopharm Medi Immune Dec., 201326. Tegaserod Gastro Novartis April, 201327. Montelukast Respiratory Merck Oct, 201328. Grepafloxacin Antibiotic Glaxo Dec, 201329. Colesevelam C.V. Geltek Dec, 201430. Linezolid Antibiotic Pharmacia Nov, 201431. Posaconazole Antibiotic Shering Aug, 201432. Idiotypic CEA Oncology Titan Dec, 201433. Insulin Glargin Diabetes Aventis April, 201434. Transtuzumab Biopharm Gentech Oct, 201435. Esomeprazole Gastro A.Z. May, 201436. Telmistran C.V.   Jan, 201437. Omaptrilar  C.V. B.M. June, 201538. Telethromycin Antibiotic Aventis April, 201539. Gemifloxacin Antibiotic GSK June, 201540. Alemtuzumb Oncology Millennium Dec, 201541. Abciximab Biopharm Gentocore June, 201542. Omalizumb Respiratory Roche Feb, 2015

Page 2: List of the Drugs Going Off Patent in Near Future

43. Pitavastatin C.V. Nissan Jan, 2016